Literature DB >> 30864153

Gene therapy improves brain white matter in aromatic l-amino acid decarboxylase deficiency.

Chih-Hsien Tseng1, Yin-Hsiu Chien2, Ni-Chung Lee2, Yung-Chin Hsu3, Shinn-Forng Peng3, Wen-Yih I Tseng3,4, Wuh-Liang Hwu2.   

Abstract

OBJECTIVE: Children with aromatic l-amino acid decarboxylase (AADC) deficiency suffer from severe motor dysfunction. Restoration of dopamine levels in the putamen by gene therapy has led to significant improvement in motor function. This study explored brain structure changes in patients.
METHODS: Brain diffusion tensor imaging (DTI) was performed before and 12 months after gene therapy. Whole-brain tract-specific analysis was performed to assess white matter microstructural integrity.
RESULTS: In the 8 patients (aged 1.67-8.42 years) enrolled in the study, gene therapy did not affect macroscopic structure. DTI before gene therapy revealed lower total mean fractional anisotropy (FA) values in patients than in the age-matched pretreatment controls (p = 0.017; median difference = -0.0136; 95% confidence interval [CI] [-0.0319, -0.0126]). After gene therapy, total mean FA increased (p = 0.012, median difference = 0.0211, 95% CI [0.0094, 0.0456]), and the values in the patients were not different from the age-matched posttreatment controls. Increase in total mean FA after gene therapy in patients was correlated with their increase in motor score (r = 0.846; p = 0.008), but was inversely correlated with their ages at the time of gene therapy (r = -0.754; p = 0.031). Corticospinal tracts, and the thalamic radiation and callosal fibers involving motor function, improved after gene therapy.
INTERPRETATION: Improvement in the microstructural integrity of white matter tracts is associated with the improvement in motor function following gene therapy. Ann Neurol 2019;85:644-652.
© 2019 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30864153     DOI: 10.1002/ana.25467

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  6 in total

1.  Viral Vector-Mediated Gene Transfer of Glutamic Acid Decarboxylase for Chronic Pain Treatment: A Literature Review.

Authors:  Megumi Kanao-Kanda; Hirotsugu Kanda; Shue Liu; Sabita Roy; Michal Toborek; Shuanglin Hao
Journal:  Hum Gene Ther       Date:  2020-03-24       Impact factor: 5.695

2.  Combining neuroimaging and behavior to discriminate children with attention deficit-hyperactivity disorder with and without prenatal alcohol exposure.

Authors:  Joseph O'Neill; Mary J O'Connor; Guldamla Kalender; Ronald Ly; Andrea Ng; Andrea Dillon; Katherine L Narr; Sandra K Loo; Jeffry R Alger; Jennifer G Levitt
Journal:  Brain Imaging Behav       Date:  2021-06-05       Impact factor: 3.978

Review 3.  A Proposed Diagnostic Algorithm for Inborn Errors of Metabolism Presenting With Movements Disorders.

Authors:  Juan Darío Ortigoza-Escobar
Journal:  Front Neurol       Date:  2020-11-13       Impact factor: 4.003

4.  Oculogyric crisis mimicked epilepsy in a Chinese aromatic L-amino acid decarboxylase-deficiency patient: A case report.

Authors:  Hongmei Wang; Jiahong Li; Ji Zhou; Lifang Dai; Changhong Ding; Mo Li; Weixing Feng; Fang Fang; Xiaotun Ren; Xiaohui Wang
Journal:  Front Neurol       Date:  2022-09-01       Impact factor: 4.086

5.  Case report: First case report of an Emirati child with a novel gene variant causing aromatic L-amino acid decarboxylase deficiency.

Authors:  Mohamed O E Babiker; Manju A Kurian; Jehan Suleiman
Journal:  Front Pediatr       Date:  2022-08-30       Impact factor: 3.569

6.  Ultrastructural and diffusion tensor imaging studies reveal axon abnormalities in Pompe disease mice.

Authors:  Ni-Chung Lee; Wei-Hao Peng; Li-Kai Tsai; Yen-Hsu Lu; Hao-Chun Wang; Yao-Chia Shih; Zeng-Xian Pung; Hsi-Yuan Hu; Wuh-Liang Hwu; Wen-Yih Isaac Tseng; Yin-Hsiu Chien
Journal:  Sci Rep       Date:  2020-11-19       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.